A study has found that semaglutide, a drug originally developed to treat type 2 diabetes and sold by Novo Nordisk as brands Wegovy and Ozempic, cut alcohol consumption in patients by about 40% and reduced the desire to drink.
Weight-loss Drug Shows Promise in Reducing Alcohol Consumption